Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance

Seventh Sense Biosystems Inc. (7SBio) announced that a new blood collection device called TAP has received U.S. Food and Drug Administration 510(k) clearance. The technology represents a landmark innovation in the blood collection industry where one billion blood draws are performed each year for diagnostic testing.

Read More »

HealthSTAR Communications Expands its Strategic Offerings with Launch of HealthSTAR Fusion Group

HealthSTAR Communications announced the launch of HealthSTAR Fusion Group, an important new addition to its strategic network of companies.

Read More »

Results from recent Alzheimer’s disease trials validate the ProMIS approach

ProMIS Neurosciences announced it has issued a scientific white paper entitled “Results from recent Alzheimer’s disease trials validate the ProMIS approach.”

Read More »

Thermo Fisher did not infringe genetic-test patent

The U.S. Supreme Court cleared a subsidiary of biotech company Thermo Fisher Scientific Inc. of infringing a genetic-testing kit patent held by Promega Corp.

Read More »

Philips upbeat on prospects for new image-guided therapy platform

Philips announced the introduction of a new platform for image guided therapy that enables doctors to combine the use of several medical scanners, imaging data and large screen displays as they perform minimally invasive surgeries.

Read More »

CVS removes artificial trans fats from its food brands

CVS Health Corp. said its pharmacy chain had removed artificial trans fats, which have been linked to rising rates of heart diseases, from its store-branded food products well ahead of a June 2018 federal deadline.

Read More »

FDA Accepts NDA Resubmission for DEXTENZA

Ocular Therapeutix’s NDA resubmission for DEXTENZA 0.4 mg for ocular pain occurring after ophthalmic surgery was accepted as a filing for review by FDA.

Read More »

Massachusetts’ Agenus Quietly Discloses Failure of Cancer Vaccine Trial

Lexington, Mass.-based Agenus quietly filed with the U.S. Securities and Exchange Commission (SEC) that it was halting the company’s clinical trial of its cancer vaccine Prophage.

Read More »

Pfizer, Celgene, Eli Lilly, Merck & Co. CEOs and Other Execs Send Letter Supporting GOP Tax Plan

Chief executive officers from more 16 large manufacturing companies – including pharma leaders from Celgene, Dow Chemical, Eli Lilly, Merck and Pfizer – penned a letter to Congressional leaders in support of a Republican-backed tax reform plan.

Read More »

Serial Investor Carl Icahn Takes Stake in Bristol-Myers Squibb, Stock Jumps

Hours after Bristol-Myers Squibb announced a $2 billion stock buyback plan, billionaire investor Carl Icahn snapped up a “large stake” of BMS stock, which sent shares soaring.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom